APA (7th ed.) Citation

Graham, D. L., Gray, A. J., Joyce, J. A., Yu, D., O'Moore, J., Carlson, G. A., . . . Hering, H. (2014). Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy. Neuropharmacology, 79, 307-313. https://doi.org/10.1016/j.neuropharm.2013.11.025

Chicago Style (17th ed.) Citation

Graham, Danielle L., Audrey J. Gray, John A. Joyce, Dongzi Yu, Jill O'Moore, George A. Carlson, Mark S. Shearman, Tammy L. Dellovade, and Heike Hering. "Increased O-GlcNAcylation Reduces Pathological Tau Without Affecting Its Normal Phosphorylation in a Mouse Model of Tauopathy." Neuropharmacology 79 (2014): 307-313. https://doi.org/10.1016/j.neuropharm.2013.11.025.

MLA (9th ed.) Citation

Graham, Danielle L., et al. "Increased O-GlcNAcylation Reduces Pathological Tau Without Affecting Its Normal Phosphorylation in a Mouse Model of Tauopathy." Neuropharmacology, vol. 79, 2014, pp. 307-313, https://doi.org/10.1016/j.neuropharm.2013.11.025.